COMMUNIQUÉS West-GlobeNewswire
-
ColestZen Official Launch 2026 - Natural Cholesterol Support Supplement for Adults (US, UK, Canada, and Australia)
20/07/2026 -
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
20/07/2026 -
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
20/07/2026 -
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
20/07/2026 -
Frishantic Launches Chelated Magnesium Glycinate for Nighttime Calm and Daily Muscle Ease
20/07/2026 -
Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors
20/07/2026 -
CLINUVEL’s ADS to commence trading on Nasdaq
20/07/2026 -
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
20/07/2026 -
Burntide Gummies Launch 2026 | Advanced Weight Loss Formula Highlights Ingredients, Supplement Facts Available in USA, UK, CA, By BurnTide.
19/07/2026 -
ColestZen Official Launch 2026 | Cholesterol Support Capsules Available in USA, UK, CA & AU Market By Colestzen Supplement.
18/07/2026 -
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
18/07/2026 -
2,300+ cyclists pedal to a record-breaking $12.5M for Alberta cancer care
18/07/2026 -
La Society for Medical Decision Making décerne le 2026 Career Achievement Award à Uwe Siebert, professeur à Harvard et à UMIT TIROL
18/07/2026 -
Vireo Growth Inc. Completes Acquisition of Pennsylvania Dispensary License Transaction
18/07/2026 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
17/07/2026 -
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales
17/07/2026 -
DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars
17/07/2026 -
Arizona Nonprofit Launches First-Ever Electric Vehicle Fundraiser Featuring the Iconic Volkswagen ID. Buzz
17/07/2026 -
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17/07/2026
Pages